These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 645659)

  • 21. Hepatic function tests in children with sickle cell anaemia during vaso occlusive crisis.
    Ojuawo A; Adedoyin MA; Fagbule D
    Cent Afr J Med; 1994 Dec; 40(12):342-5. PubMed ID: 7882414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaso-occlusive crisis-associated neutrophil dysfunction in patients with sickle-cell disease.
    Lachant NA; Oseas RS
    Am J Med Sci; 1987 Oct; 294(4):253-7. PubMed ID: 3661621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A holistic approach to vaso-occlusive pain crisis in children with sickle cell disease.
    Houser B; Plawecki HM; Carr J; Smith MA; Plawecki JA
    J Holist Nurs; 1992 Mar; 10(1):62-75. PubMed ID: 1293205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis.
    Akinola NO; Stevens SM; Franklin IM; Nash GB; Stuart J
    Br J Haematol; 1992 Aug; 81(4):598-602. PubMed ID: 1390248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis.
    Ekwere TA; Ebele U; Ekanem M; Ogunro PS
    Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
    Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
    N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
    Tantawy AA; Adly AA; Ismail EA
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin response to anaemia in children with sickle cell disease and Fanconi's hypoproliferative anaemia.
    McGonigle RJ; Ohene-Frempong K; Lewy JE; Fisher JW
    Acta Haematol; 1985; 74(1):6-9. PubMed ID: 3934912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute pancreatitis during sickle cell vaso-occlusive painful crisis.
    Ahmed S; Siddiqui AK; Siddiqui RK; Kimpo M; Russo L; Mattana J
    Am J Hematol; 2003 Jul; 73(3):190-3. PubMed ID: 12827657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperfibrinogenaemia and hyperviscosity in sickle-cell crisis.
    Richardson SG; Breeze GR; Stuart J
    J Clin Pathol; 1976 Oct; 29(10):890-3. PubMed ID: 977763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukocyte counts in children with sickle cell disease.
    Karayalcin G; Kim YJ; Lanzkowsky P
    Am J Dis Child; 1979 Mar; 133(3):331-2. PubMed ID: 425950
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease.
    Conran N; Saad ST; Costa FF; Ikuta T
    Ann Hematol; 2007 Apr; 86(4):255-61. PubMed ID: 17205286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A; Gumruk F; Gurgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of sickle cell-beta0 thalassaemia with homozygous sickle cell disease.
    Serjeant GR; Sommereux AM; Stevenson M; Mason K; Serjeant BE
    Br J Haematol; 1979 Jan; 41(1):83-93. PubMed ID: 420738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of copeptin, C-reactive protein and cortisol in different severity groups of sickle cell anaemia.
    Akinlade KS; Atere AD; Rahamon SK; Olaniyi JA
    Niger J Physiol Sci; 2013 Dec; 28(2):159-64. PubMed ID: 24937391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
    Setty BN; Chen D; Stuart MJ
    Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyarthritis and positive LE preparation in sickle hemoglobinopathies: a report of two cases.
    White LE; Reeves JD
    J Pediatr; 1979 Dec; 95(6):1003-4. PubMed ID: 91679
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxygen delivery index in homozygous sickle cell disease: steady and crisis states.
    Bowers AS; Pepple DJ; Reid HL
    Br J Biomed Sci; 2009; 66(3):148-9. PubMed ID: 19839226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is sickle cell crisis a thrombotic event?
    Green D; Scott JP
    Am J Hematol; 1986 Dec; 23(4):317-21. PubMed ID: 3788960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.